Bion Debuts First Rx At-Home Tumor Marker Assay For Bladder Cancer
This article was originally published in The Gray Sheet
Executive Summary
Bion Diagnostic Sciences' BTA stat tumor marker assay for bladder cancer, the first such test to enter the prescription at-home market, is expected to be available in mid-February following FDA clearance Dec. 17.